Today: 17 April 2026
Subscribe
Browse Category

OTC:HNGKY 8 December 2025

Hongkong Land Holdings (SGX: H78) Stock Outlook 2026: Buybacks, Deep Discount to NAV and a Stabilising Hong Kong Office Market

Hongkong Land Holdings (SGX: H78) Stock Outlook 2026: Buybacks, Deep Discount to NAV and a Stabilising Hong Kong Office Market

Hongkong Land shares traded at US$6.70 on the Singapore Exchange as of 8 December 2025, up sharply this year amid buybacks and asset sales. Third-quarter underlying profit fell 13% year-on-year. The stock trades at about 0.49 times book value, near a 10-year high but still roughly 50% below net asset value. Analyst forecasts remain divided on the outlook.
8 December 2025
····

Stock Market Today

  • Belden (BDC) Overvalued After Strong Gains, DCF Model Suggests
    April 16, 2026, 6:55 PM EDT. Belden (BDC) shares rise 60.7% over three years but face pressure. The stock trades near $126, about 13.1% above its intrinsic value of $111.69 estimated by a discounted cash flow (DCF) model. Belden showed 34.6% return in the past year, lagging peers. Investors weigh its strong position in connectivity and networking products against valuation concerns. The DCF model forecasts free cash flow growth to $314 million by 2028, yet current price exceeds cash flow-based value. Belden scores 4 out of 6 on valuation checks, indicating some undervaluation elsewhere but overall overvaluation per DCF. The P/E ratio remains relevant to assess earnings price alignment amid these mixed signals. Investors should consider risk and opportunity carefully amid recent gains.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Go toTop